| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |